Drug Discovery Featured Articles & Applications

  1. When To Build Out Your ClinOps Team — And Other Advice For First-Time Biotechs 10/26/2026

    Small biotechs shouldn't model their ClinOps headcount after Big Pharma. Instead, they need the right capabilities, oversight, and risk controls. Consultant Jessica Cordes explains.

  2. Beyond RAG: When To Use Semantics, Retrieval, Graph, And Agent Inference 10/26/2026

    Most large pharmaceutical organizations already own many of the components required for layered architecture. The problem is that these systems often evolve independently.

  3. Can CoRegen's Treg Platform Dismantle Solid Tumors' Immune Shield? 10/22/2026

    Backed by $93 million, CoRegen is bringing a novel Treg-engineering strategy into the clinic to test whether CRG-150 can dismantle solid tumors’ immune defenses.

  4. Beyond RAG: Why Life Sciences AI Workflows Need Better Context, Not Just Better Models 10/21/2026

    Teams want AI systems that can answer complex scientific questions across value chain, but as these systems move closer to production, a recurring problem is becoming visible.

  5. Using Recurring Toxicity Profiles To Inform Preclinical Study Design 10/20/2026

    In this preliminary analysis of regulatory reviews, toxicity profiles were constructed from nonclinical animal findings.

  6. Discovery & Development US 2026 - Key Notes From San Diego 10/19/2026

    Key takeaways from D&D US 2026 on Pfizer’s complex oncology targets, AI-enabled discovery, and the shift toward human-based NAMs.

  7. A Quantitative Procurement Framework For Scaling Organ-On-A-Chip Adoption Across Markets Of Varying Maturity 10/16/2026

    OoC commercialization is moving beyond technical feasibility toward reproducible, scalable, and economically viable adoption. Achieving this shift requires procurement to move beyond unit-price negotiations.

  8. Drug Discovery's Hidden Feedback Loop 10/14/2026

    Some of the most valuable insights may not come from the next experiment, but from past experiments.

  9. Benefit Of Being Bitten: Repeat Mosquito Exposure Could Build Immunity 10/9/2026

    A new malaria study explores a fundamentally different approach to malaria prevention: using mosquito bites themselves as repeated immune-boosting events.

  10. Inside Discovery On Target 2026: New Modalities, AI, And A Higher Funding Bar 10/7/2026

    Discovery on Target 2026 showed how new modalities and AI are expanding drug discovery as investors demand stronger data and clearer paths to value.